The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder
Year: 2008
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Institutions: Bristol-Myers Squibb (United States), Philadelphia VA Medical Center, University of Pittsburgh Medical Center, University of Pennsylvania, Otsuka (United States), Otsuka Pharmaceutical Development & Commercialization, Inc. (United States), Bristol-Myers Squibb (Belgium), Massachusetts General Hospital, Sherbrooke Research and Development Centre, The University of Texas Southwestern Medical Center
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2007880575
